Astellas Pharma Inc (ALPMY)

$9.54 -0.09 (-0.93%)
Market Cap 17.43B
Revenue (ttm) 10.62B
Net Income (ttm) 113.00M
EPS (ttm) N/A
PE Ratio 16.16
Forward PE 15.89
Profit Margin 1.06%
Debt to Equity Ratio 0.61
Volume 161,800
Avg Vol 282,936
Day's Range N/A - N/A
Shares Out 1.81B
Stochastic %K 39%
Beta 0.34
Analysts Sell
Price Target $12.00

Latest News on ALPMY

No data available.